Clinical Trial Update: Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy of ophthalmic pazufloxacin 0.6% vs gatifloxacin 0.3% for bacterial conjunctivitis; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• Gatifloxacin 0.3% (gatifloxacin)
• Pazufloxacin 0.6% (pazufloxacin)

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Conjunctivitis, Bacterial | Phase 3 | Status: TERMINATED | Results posted: 2021-08-24